Recent advancements for which condition can increase life expectancy for affected individuals?

Edward's Syndrome, or trisomy 18, is a genetic condition characterized by severe developmental delays due to an extra chromosome 18. Most children with this syndrome have a range of serious health issues, and historically, life expectancy has been significantly limited, often only living for a few months to a year. However, advancements in medical care, including improved prenatal screening, neonatal care, and tailored interventions, have led to an increase in life expectancy for some individuals affected by Edward's Syndrome. This includes better management of associated medical problems and more informed decisions regarding treatment options.

In contrast, while conditions like Down Syndrome, Turner Syndrome, and Angelman Syndrome have seen advancements in care and support, the life expectancy for individuals with those conditions has generally increased over the years due to social services, medical advancements, and educational support rather than specific recent advancements directly tied to medical treatments that significantly extend life expectancy in the same way observed for Edward's Syndrome.